Concept Life Sciences Expands GXP Compliance

Concept Life Sciences, the integrated drug discovery, development and analytical services company, today announced the completion of the first phase of its GXP compliance plan, achieving GLP (good laboratory practice) accreditation of its Dundee site for in vitro safety studies and bioanalysis. The successful MHRA inspection was carried out at Concept’s Dundee site in December 2017, confirming GLP accreditation for in vitro safety studies and...

Aberdeen named partners in project to transform health through data science

Researchers at the University of Aberdeen have been named within an important partnership which will receive a portion of a £54 million research fund focussed on using data science to address challenging healthcare issues. The University of Aberdeen form part of the Health Data Research UK partnership because of its reputation for world-class expertise, its track record in using health data to derive new knowledge,...

ClinSpex DX – Triage ID system installed at Edinburgh’s Western General Hospital

The ClinSpec Dx – Triage ID system has now been installed at Western General Hospital in Edinburgh and is currently recruiting prospective patients for a clinical feasibility study, alongside the Wellcome Trust. Patients with a suspected brain tumour will be recruited for their simple blood test, and a rapid result with be provided to clinicians to aid their treatment decision. This study is in advance of their...

University of Glasgow Partners with Portage Pharmaceuticals

A new joint venture company which brings together the University of Glasgow and Portage Pharmaceuticals is aiming to develop more effectively-targeted drugs to treat chronic conditions including cancer. Portage Pharmaceuticals, a subsidiary of the British Virgin Islands-based Portage Biotech,Inc. (OTCQB: PTGEF, Canadian Stock Exchange: PBT.U), is providing an undisclosed funding injection to the new business, called Portage Glasgow Limited, along with a limited license to...

Parkinson’s breakthrough: Home monitor allowing better targeted treatment

New software has been developed which can detect a side-effect of treatment that causes involuntary jerking movements. Prolonged exposure to the dopamine replacement drugs used to treat Parkinson’s can lead to dyskinesia – involuntary jerking and spasms of the body. Researchers at Heriot-Watt University in Edinburgh said the software reliably detects the condition. They are now using their findings to develop a home monitor that...

$16million contract win for Craneware

Healthcare billing company Craneware has secured a contract worth in excess of $16m over five years as it continues to perform strongly. In an update on the first half of the financial year the Edinburgh-based business has seen strong underlying sales growth. This has been underpinned by a “significant” new contract with one of the largest healthcare provider networks in the US.  To read the...

Top